AlphaYouJS
Insider buying
John S. Montalbano bought $110K of AbCellera Biologics Inc. (ABCL) stock
John S. Montalbano, Dir of AbCellera Biologics Inc. (ABCL), bought 10,000 shares of ABCL stock worth $110K, per an SEC Form 4 filed Aug 18, 2026.
It was an open-market purchase.
The trade was reported on Aug 18, 2026.
ABCL has moved +13.8% since the trade date, from $11.12 to $12.66 (Sep 21, 2026 close).
- Traded
- Aug 18, 2026
- Disclosed
- Aug 18, 2026
- Filing delay
- 0 days
- Price since
- +13.8%
- Role
- Dir
- Source
- SEC Form 4
More ABCL insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.